## New Breakthrough Uncovers the True Cause Behind Chronic Colitis
**A groundbreaking study paves the way for treatingchronic inflammation in Ulcerative Colitis, a disease affecting over 5 million
people worldwide.**
 |
| ## New Breakthrough Uncovers the True Cause Behind Chronic Colitis |
## New Breakthrough Uncovers the True Cause Behind Chronic Colitis
Scientists at the Medical University of Graz,
Austria,have made a significant scientific discovery regarding a novel mechanism that explains one of the causes of chronic inflammation in Ulcerative Colitis (UC).
- This inflammatory bowel disease, which impacts over 5 million individuals
- globally, is characterized by recurrent episodes of inflammation in the lining
- of the colon. UC specifically targets the lining of the colon and rectum,
- leading to superficial inflammation and ulcerations in the mucosal membrane.
For decades, the precise causes of Ulcerative Colitis
remained largely unknown. However, an international research team has now
published findings that they believe will "pave the way for more precise
therapeutic strategies and help reduce chronic inflammation in patients who do
not respond to current treatments or suffer from recurrent relapses." The
study's results were published in the prestigious journal "Nature
Communications."
In their detailed investigation, the research team unveiled a new and intriguing mechanism contributing to the onset of this chronic inflammation. By analyzing samples of colonic fluids and tissues from UC patients, researchers discovered that bacteria residing in the gut do not merely exert their influence through direct presence,
but also through the secretion of tiny microscopic vesicles known as "Bacterial Extracellular Vesicles" (BEVs). These BEVs carry bacterial components such as proteins, DNA fragments, and substances that actively stimulate inflammation.
### Counterintuitive Outcomes
The study observed a significant number of these BEVs
enveloped by a type of antibody called Immunoglobulin A (IgA). While IgA
typically plays a crucial role in protecting mucous membranes from harmful
bacteria, in this specific context, this encapsulation leads to a
counterintuitive and detrimental outcome.
- These IgA-coated BEVs directly bind to a specific receptor, known as CD89,
- located on certain immune cells within the intestines. When this binding
- occurs, the immune cells respond excessively, triggering a robust
- inflammatory response that results in tissue damage and persistent
- inflammation in the colon.
This discovery marks the first time it has been established that
these small bacterial vesicles—previously considered mere cellular waste
products or bacterial transport vehicles—play a pivotal role in initiating
inflammation when coated with IgA.
### The Trojan Horse Mechanism
Researchers have likened this newly identified
mechanism to a "Trojan Horse." The IgA-coated BEVs appear innocuous
or harmless on the surface, but in reality, they carry inflammatory cargo that
is delivered into immune cells via the IgA antibody, thereby exacerbating
inflammation.
- Many patients with Ulcerative Colitis do not respond well to immune-
- targeting treatments or experience frequent relapses. The researchers propose
- that these bacterial vesicles could represent a novel therapeutic target. This
- understanding could facilitate the development of new treatments designed to
- prevent the formation of BEVs, inhibit their encapsulation by IgA, or even
- block their interaction with the CD89 receptor.
The study, according to its authors, underscores the
importance of examining the gut microbiome from a new perspective. This
perspective extends beyond merely considering the types of bacteria present, to
encompass what these bacteria secrete and how the immune system interacts with
these secretions.
Chronic colitis, or Ulcerative Colitis, is a disease affecting the large intestine, characterized by recurrent inflammation and ulcerations in the lining of the colon. It causes frequent diarrhea, abdominal pain, rectal bleeding, and persistent fatigue.
Among its causes are immune
system dysfunction combined with genetic and environmental factors. Individuals
diagnosed with UC require ongoing medical monitoring and long-term treatment to
manage inflammation and prevent complications.
